FHTX

Foghorn Therapeutics (FHTX)

Foghorn Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:FHTX

1 2 3 4 5 6 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/12/30	21 : 54	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/12/16	21 : 04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/12/16	21 : 00	GlobeNewswire Inc.	Foghorn Therapeutics Provides Update on FHD-286 Clinical Development Program and Strategic Priorities	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/11/12	21 : 54	GlobeNewswire Inc.	Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/11/05	06 : 14	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/11/05	06 : 12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/10/23	21 : 00	PR Newswire (US)	Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/10/10	20 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/10/10	20 : 00	GlobeNewswire Inc.	Foghorn Therapeutics Announces First Patient Dosed with First-in-Class Oral SMARCA2 Selective Inhibitor FHD-909 in a Phase 1 Trial for SMARCA4 Mutated Solid Tumors	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/10/09	06 : 44	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/10/03	21 : 00	PR Newswire (US)	Invaio Sciences Appoints André Andonian as Chairman of the Board of Directors	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/10/01	20 : 00	GlobeNewswire Inc.	Foghorn Therapeutics to Participate in the BMO Oncology Summit	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/09/25	05 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/09/21	05 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/09/19	05 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/09/17	05 : 40	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/09/12	05 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/09/10	05 : 31	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/09/05	05 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/09/05	05 : 00	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/09/03	20 : 00	GlobeNewswire Inc.	Foghorn Therapeutics Strengthens Leadership Team with Appointment of Anna Rivkin, Ph.D. as Chief Business Officer	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/08/28	20 : 00	GlobeNewswire Inc.	Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences in September	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/08/08	21 : 44	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/08/08	20 : 04	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/08/08	20 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/08/06	19 : 30	PR Newswire (US)	Flagship Pioneering Announces Appointment of Raj Panjabi as Senior Partner	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/06/04	05 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/05/28	20 : 00	GlobeNewswire Inc.	Foghorn Therapeutics to Participate in Upcoming Investor Conferences in June	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/05/23	20 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FHTX	Foghorn Therapeutics Inc
2024/05/23	07 : 21	GlobeNewswire Inc.	Foghorn Therapeutics Raises Approximately $110 Million Through Registered Direct Offering to Advance Pipeline	NASDAQ:FHTX	Foghorn Therapeutics Inc